Cell Growth & Differentiation, Vol 8, Issue 3 293-299, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis

J Houldsworth, V Reuter, GJ Bosl and RS Chaganti
Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Human male germ cell tumors (GCTs) arise in the spermatocytic lineage, and subsets display embryonal-like differentiation. Virtually all GCTs exhibit multiple copies of the short arm of chromosome 12, even in carcinoma in situ/intratubular germ cell neoplasia, the earliest recognizable neoplastic lesion of germ cells. Among the candidate amplified genes mapped to 12p, expression of the cyclin D2 gene (CCND2) was deregulated in a panel of GCT cell lines, with the relative level of steady-state mRNA and protein inversely correlated with the pattern of differentiation characteristic of the cell line. GCT cell lines with a more differentiated phenotype, as indicated by an immunophenotypic analysis, displayed lower cyclin D2 expression with a concurrent increase in expression of the cell cycle inhibitor p21. In the GCT cell lines in which cyclin D2 was highly expressed, cyclin D2 was in complex with its expected catalytic partners (Cdk4 and Cdk6). Whereas no detectable cyclin D2 expression was evident in normal human germ cells, cyclin D2 was expressed in the abnormal germ cells of all carcinoma in situ/intratubular germ cell neoplasia lesions studied. In GCT specimens that displayed no evidence of differentiation (seminoma) or primitive differentiation (embryonal carcinoma), cyclin D2 expression was detected. However, in tumor specimens with certain patterns of differentiation (teratoma and yolk sac tumor), expression was down- or up-regulated depending on the pattern. Our data suggest that aberrant cyclin D2 expression is an early event in germ cell tumorigenesis.

This article has been cited by other articles:

				E. RAJPERT-DE MEYTS and C. E. HOEI-HANSEN From Gonocytes to Testicular Cancer: The Role of Impaired Gonadal Development Ann. N.Y. Acad. Sci., December 1, 2007; 1120(1): 168 - 180. [Abstract] [Full Text] [PDF]

				L. H. J. LOOIJENGA, AD. J. M. GILLIS, H. J. STOOP, R. HERSMUS, and J. W. OOSTERHUIS Chromosomes and Expression in Human Testicular Germ-Cell Tumors: Insight into Their Cell of Origin and Pathogenesis Ann. N.Y. Acad. Sci., December 1, 2007; 1120(1): 187 - 214. [Abstract] [Full Text] [PDF]

				J. Houldsworth, J. E. Korkola, G. J. Bosl, and R. S. K. Chaganti Biology and Genetics of Adult Male Germ Cell Tumors J. Clin. Oncol., December 10, 2006; 24(35): 5512 - 5518. [Abstract] [Full Text] [PDF]

				E. Rajpert-De Meyts Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects Hum. Reprod. Update, May 1, 2006; 12(3): 303 - 323. [Abstract] [Full Text] [PDF]

				J. E. Korkola, J. Houldsworth, R. S.V. Chadalavada, A. B. Olshen, D. Dobrzynski, V. E. Reuter, G. J. Bosl, and R.S.K. Chaganti Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors Cancer Res., January 15, 2006; 66(2): 820 - 827. [Abstract] [Full Text] [PDF]

				D. Juric, S. Sale, R. A. Hromas, R. Yu, Y. Wang, G. E. Duran, R. Tibshirani, L. H. Einhorn, and B. I. Sikic Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures PNAS, December 6, 2005; 102(49): 17763 - 17768. [Abstract] [Full Text] [PDF]

				C.E. Hoei-Hansen, J.E. Nielsen, K. Almstrup, M.A. Hansen, N.E. Skakkebaek, E. Rajpert-DeMeyts, and H. Leffers Identification of genes differentially expressed in testes containing carcinoma in situ Mol. Hum. Reprod., June 1, 2004; 10(6): 423 - 431. [Abstract] [Full Text] [PDF]

				R. I. Skotheim, O. Monni, S. Mousses, S. D. Fossa, O.-P. Kallioniemi, R. A. Lothe, and A. Kallioniemi New Insights into Testicular Germ Cell Tumorigenesis from Gene Expression Profiling Cancer Res., April 1, 2002; 62(8): 2359 - 2364. [Abstract] [Full Text] [PDF]

				B. A. Schmidt, A. Rose, C. Steinhoff, T. Strohmeyer, M. Hartmann, and R. Ackermann Up-Regulation of Cyclin-dependent Kinase 4/Cyclin D2 Expression but Down-Regulation of Cyclin-dependent Kinase 2/Cyclin E in Testicular Germ Cell Tumors Cancer Res., May 1, 2001; 61(10): 4214 - 4221. [Abstract] [Full Text]

				T. L. Beumer, H. L. Roepers-Gajadien, I. S. Gademan, H. B. Kal, and D. G. de Rooij Involvement of the D-Type Cyclins in Germ Cell Proliferation and Differentiation in the Mouse Biol Reprod, December 1, 2000; 63(6): 1893 - 1898. [Abstract] [Full Text]

				V. G. Dyomin, N. Palanisamy, K. O. Lloyd, K. Dyomina, S. C. Jhanwar, J. Houldsworth, and R. S. K. Chaganti MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets Blood, April 15, 2000; 95(8): 2666 - 2671. [Abstract] [Full Text] [PDF]

				R. S. K. Chaganti and J. Houldsworth Genetics and Biology of Adult Human Male Germ Cell Tumors Cancer Res., March 1, 2000; 60(6): 1475 - 1482. [Abstract] [Full Text]

				R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF]

				M. Meyyappan, H. Wong, C. Hull, and K. T. Riabowol Increased Expression of Cyclin D2 during Multiple States of Growth Arrest in Primary and Established Cells Mol. Cell. Biol., June 1, 1998; 18(6): 3163 - 3172. [Abstract] [Full Text]